COCRYSTAL PHARMA, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- COCRYSTAL PHARMA, INC. stock issued during period, value, new issues for the quarter ending 2025-09-30 was $154.00K.
- COCRYSTAL PHARMA, INC. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $4.00M.
- COCRYSTAL PHARMA, INC. stock issued during period, value, new issues for the quarter ending 2021-06-30 was $36.43M.
- COCRYSTAL PHARMA, INC. stock issued during period, value, new issues for the quarter ending 2021-03-31 was $2.07M, a 87.52% decline year-over-year.
- COCRYSTAL PHARMA, INC. stock issued during period, value, new issues for fiscal 2025 was $154.00K.
- COCRYSTAL PHARMA, INC. stock issued during period, value, new issues for fiscal 2023 was $4.00M.
- COCRYSTAL PHARMA, INC. stock issued during period, value, new issues for fiscal 2021 was $38.51M, a 7.61% increase from fiscal 2020.
- COCRYSTAL PHARMA, INC. stock issued during period, value, new issues for fiscal 2020 was $35.78M, a 439.06% increase from fiscal 2019.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $154.00K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $154.00K 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $4.00M 10-K · filed 2025-03-31 | |
| 2023-06-30 | $4.00M 10-Q · filed 2024-11-13 | |
| 2021-12-31 | $38.51M 10-K · filed 2023-03-29 | |
| 2021-06-30 | $36.43M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $2.07M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $35.78M 10-K · filed 2022-03-23 | |
| 2020-09-30 | $15.55M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $16.61M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $6.64M 10-K · filed 2021-03-17 | |
| 2019-03-31 | $3.93M 10-Q · filed 2020-11-13 | |
| 2018-12-31 | $7.68M 10-K · filed 2020-03-27 | |
| 2018-06-30 | $7.68M 10-Q · filed 2019-11-12 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-01 | $3.00M 10-K · filed 2019-04-01 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | |
| 2016-12-31 | $9.01M 10-K · filed 2018-03-21 | |
| 2015-12-31 | $15.86M 10-K · filed 2018-03-21 | |
| 2013-12-31 | $1.95M derived: 10-K 12 month − 3 quarters · filed 2014-03-31 | $950.00K 10-K · filed 2014-03-31 |
| 2013-09-30 | -$500.00K 10-Q · filed 2013-11-18 | $150.00K derived: sum of 4 quarters · filed 2014-03-31 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-15 | $650.00K derived: sum of 4 quarters · filed 2014-03-31 |
| 2013-03-31 | -$500.00K 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $1.15M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-31 | $650.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-14 | |
| 2011-12-31 | $705.00K 10-K · filed 2013-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |